000 | 01865nim a2200505 a 4500 | ||
---|---|---|---|
001 | HST8148 | ||
003 | UkLoHST | ||
006 | m o h | ||
007 | cr nna|||||||| | ||
007 | sr |mnnnnnzne| | ||
008 | 200404s2020 enk|||||o||h||||||||eng d | ||
028 | 5 | 0 |
_a8148 _bHenry Stewart Talks |
035 | _a(UkLoHST)4215 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aPlotkin, Stanley A., _d1932- _4spk |
|
245 | 1 | 0 |
_aSARS-CoV-2 vaccine development _h[electronic resource] / _cStanley Plotkin. |
260 |
_aLondon : _bHenry Stewart Talks, _c2020. |
||
300 | _a1 online resource (1 streaming audio file (9 min.)). | ||
490 | 1 |
_aInterviews on Covid-19, _x2056-452X |
|
500 | _aAudio interview. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Current efforts to develop a vaccine -- Possible strategies for vaccine development -- Possible seasonal variations in virus prevalence -- When could a viable vaccine be expected?. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aCoronavirus infections. | |
650 | 0 | _aCoronaviruses. | |
650 | 0 |
_aCOVID-19 (Disease) _xVaccination. |
|
650 | 0 |
_aVaccines _xDevelopment. |
|
650 | 2 |
_aBetacoronavirus _xdrug effects. |
|
650 | 2 | _aCommunicable Diseases, Emerging. | |
650 | 2 | _aCoronavirus Infections. | |
650 | 2 | _aCOVID-19 Vaccines. | |
650 | 2 |
_aCOVID-19 _ximmunology. |
|
650 | 2 |
_aCOVID-19 _xprevention & control. |
|
650 | 2 |
_aCOVID-19 _xvirology. |
|
650 | 2 | _aDrug Development. | |
650 | 2 | _aPrevalence. | |
650 | 2 | _aSARS-CoV-2. | |
650 | 2 | _aSeasons. | |
650 | 2 | _aVaccination. | |
650 | 2 | _aViral Vaccines. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pInterviews on Covid-19. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4215/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1060/ _3Series |
999 |
_c76093 _d76093 |